Advanced Search

 

Study ID Status Title Patient Level Data
444563/028/029/030 Completed A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy and safety of two doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy infants Study Listed on ClinicalStudyDataRequest.com
444563/033 Completed Study to assess the clinical consistency of three production lots of GSK Biologicals’ HRV vaccine in terms of immunogenicity and safety when given to healthy infants at 2 and 4 months of age Study Listed on ClinicalStudyDataRequest.com
462795/007 Completed A Two-Period, Randomized, Open-Label, Parallel group, Multiple-Probe Drug Interaction Study to Determine the Effects of NCE on the metabolism of CYP450 Probe Substrates in Healthy Postmenopausal Female Subjects Study Listed on ClinicalStudyDataRequest.com
480848/005 Completed A 28 day, double blind, placebo-controlled, parallel-group dose-ranging phase IIA to examine the safety, tolerability and effects of SB-480848 on LP-PLA2 activity in dyslipidemic patients Study Listed on ClinicalStudyDataRequest.com
480848/010 Completed A multi-centre, randomised, double-blind, placebo-controlled, parallel-group study to investigate the effect of the Lp-PLA2 inhibitor SB-480848 (40, 80mg od) on carotid plaque composition in patients with carotid artery disease and planned carotid endarterectomy, stratified for statin use and gender, after 14+/-4 days treatment Study Listed on ClinicalStudyDataRequest.com
480848/012 Completed A randomized, repeat-dose, dose ranging study to evaluate the safety and pharmacokinetics of the SB480848 Enteric Coated Formulation [3A].
480848/013 Completed A Study to Evaluate the Effect of Steady-State New Chemical Entity (NCE) on the Single-Dose Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Warfarin in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
480848/014 Completed The Effect of SB-480848 on the Pharmacokinietics of Digoxin in healthy subjects (3C)
480848/015 Completed A Study to Assess the ADME and Absolute Bioavailability of SB-480848 in healthy subjects (3C)
480848/019 Completed A Study to Assess the Effect of Steady-state Omeprazole on the Pharmacokinetics of single dose SB 480848 in Healthy Adult Subjects(3C)
480848/028 Completed An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of SB-480848 in Healthy Subjects and Subjects with Moderate Hepatic Impairment Study Listed on ClinicalStudyDataRequest.com
480848/033 Completed A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE). Study Listed on ClinicalStudyDataRequest.com
480848/903 Completed A Repeat Dose, Dose Ranging Study to Evaluate the Safety and Pharmacokinetics of a Freebase Enteric Coated Formulation of SB 480848
480848/904 Completed A Study to Evaluate the Single Dose Pharmacokinetics of Enteric Coated Freebase Formulations of SB 480848 in Healthy Adults
49653/009 Completed A Multicentre, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Efficacy of Rosiglitazone When Administered to Patients With Type 2 Diabetes Mellitus. Study Listed on ClinicalStudyDataRequest.com
49653/015 Completed A Multicentre, Double-Blind, Placebo Controlled, Parallel Group Comparative Study to Evaluate the Efficacy, Safety and Tolerability of Rosiglitazone with Concurrent Sulphonylurea therapy, When Administered to Patients with Type 2 Diabetes Mellitus. Study Listed on ClinicalStudyDataRequest.com
49653/020 Completed A Multicentre, Double-Blind, Parallel Group Comparative Study to Evaluate the Efficacy, Safety and Tolerability of Rosiglitazone vs. Glibenclamide Therapy, When Administered to Patients with Type 2 Diabetes Mellitus. Study Listed on ClinicalStudyDataRequest.com
49653/025 Completed A Multicentre, Double-Blind, Parallel Group Study to Determine the Effects of Rosiglitazone on Insulin Sensitivity, Endothelial Function and Vascular Reactivity in Comparison With Metformin and Placebo When Administered to Patients With Non-insulin Dependent Diabetes Mellitus. Study Listed on ClinicalStudyDataRequest.com
49653/048 Completed A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients with Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
49653/079 Completed A 26-week Randomized, Double-Blind, Double-Dummy, Multicentered Study to Evaluate the Efficacy, Safety and Tolerability of Rosiglitazone when Administered to Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) who are Inadequately Controlled on a Maximal Dose (20 mg/day) of Glyburide. Study Listed on ClinicalStudyDataRequest.com
49653/082 Completed A 26-Week Randomized, Double-Blind, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of BRL 49653C when Administered Twice Daily to Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) who are Inadequately Controlled on Insulin Monotherapy Study Listed on ClinicalStudyDataRequest.com
49653/085 Completed A 26 Week Randomised, Double-Blind, Multicentre Study to Investigate the Effects of Rosiglitazone on Insulin Requirements in Insulin-Treated Type 2 Diabetic Patients Study Listed on ClinicalStudyDataRequest.com
49653/095 Completed A 26-week Randomised, Double-Blind, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of Rosiglitazone when Administered Once Daily to Patients with Type 2 Diabetes who are Inadequately Controlled on Insulin Monotherapy Study Listed on ClinicalStudyDataRequest.com
49653/096 Completed A 26-week Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Rosiglitazone when Administered Once Daily to Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) who are Inadequately Controlled on… Study Listed on ClinicalStudyDataRequest.com
49653/097 Completed A 3-Year Open-Label, Multicenter, Active (Glyburide) Comparison Study, to Evaluate the Effect of BRL49653C 8mg once daily on Cardiovascular Function in Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.